Insilico Medicine 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rentosertib (INS018_055) / Insilico Medicine
NCT05938920: Study Evaluating INS018_055 Administered Orally to Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Completed
2
71
RoW
INS018_055, Placebo
InSilico Medicine Hong Kong Limited
Idiopathic Pulmonary Fibrosis (IPF)
08/24
08/24
NCT05975983: Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Recruiting
2
60
US
INS018_055, Placebo
InSilico Medicine Hong Kong Limited
Idiopathic Pulmonary Fibrosis (IPF)
02/26
02/26
NCT05154240: A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

Completed
1
78
RoW
INS018_055, Placebo
InSilico Medicine Hong Kong Limited
Idiopathic Pulmonary Fibrosis
12/22
12/22
ISM5411 / Insilico Medicine
ISM5411-101, NCT06012578: Study Evaluating ISM5411 Administered Orally to Healthy Volunteers

Completed
1
79
RoW
ISM5411, Placebo
InSilico Medicine Hong Kong Limited
Healthy Subjects
09/24
09/24
ISM004-1057D / Insilico Medicine, Fosun Pharma
NCT06445517: Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma

Recruiting
1
60
RoW
ISM8207
InSilico Medicine Hong Kong Limited
Advanced Solid Tumors, Relapsed/Refractory B-cell Lymphoma
11/26
02/27
XL309 / Exelixis
NCT05932862: A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors

Recruiting
1
425
US
XL309 (ISM3091), Olaparib
Exelixis
Advanced Solid Tumor
01/29
08/29
ISM3412 / Insilico Medicine
NCT06414460: Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

Recruiting
1
80
US, RoW
ISM3412
InSilico Medicine Hong Kong Limited
Locally Advanced/Metastatic Solid Tumors
03/28
03/29
ISM033-154 / Insilico Medicine
NCT06724042: Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors

Not yet recruiting
1
159
NA
ISM5939, Cisplatin, Docetaxel, Pembrolizumab
InSilico Medicine Hong Kong Limited
Advanced Solid Tumor, Metastatic Solid Tumor, Advanced and/or Metastatic Solid Tumors
12/28
12/29
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rentosertib (INS018_055) / Insilico Medicine
NCT05938920: Study Evaluating INS018_055 Administered Orally to Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Completed
2
71
RoW
INS018_055, Placebo
InSilico Medicine Hong Kong Limited
Idiopathic Pulmonary Fibrosis (IPF)
08/24
08/24
NCT05975983: Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Recruiting
2
60
US
INS018_055, Placebo
InSilico Medicine Hong Kong Limited
Idiopathic Pulmonary Fibrosis (IPF)
02/26
02/26
NCT05154240: A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

Completed
1
78
RoW
INS018_055, Placebo
InSilico Medicine Hong Kong Limited
Idiopathic Pulmonary Fibrosis
12/22
12/22
ISM5411 / Insilico Medicine
ISM5411-101, NCT06012578: Study Evaluating ISM5411 Administered Orally to Healthy Volunteers

Completed
1
79
RoW
ISM5411, Placebo
InSilico Medicine Hong Kong Limited
Healthy Subjects
09/24
09/24
ISM004-1057D / Insilico Medicine, Fosun Pharma
NCT06445517: Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma

Recruiting
1
60
RoW
ISM8207
InSilico Medicine Hong Kong Limited
Advanced Solid Tumors, Relapsed/Refractory B-cell Lymphoma
11/26
02/27
XL309 / Exelixis
NCT05932862: A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors

Recruiting
1
425
US
XL309 (ISM3091), Olaparib
Exelixis
Advanced Solid Tumor
01/29
08/29
ISM3412 / Insilico Medicine
NCT06414460: Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

Recruiting
1
80
US, RoW
ISM3412
InSilico Medicine Hong Kong Limited
Locally Advanced/Metastatic Solid Tumors
03/28
03/29
ISM033-154 / Insilico Medicine
NCT06724042: Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors

Not yet recruiting
1
159
NA
ISM5939, Cisplatin, Docetaxel, Pembrolizumab
InSilico Medicine Hong Kong Limited
Advanced Solid Tumor, Metastatic Solid Tumor, Advanced and/or Metastatic Solid Tumors
12/28
12/29

Download Options